# Fengjia Biotechnology Ltd · 99-39 · TAIWAN — FDA import alert red lists: firms subject to detention without physical examination

For Fengjia Biotechnology Ltd · 99-39 · TAIWAN, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is TAIWAN; product is Collagen Glow Berries | Sicilian Orange Slimming Elixir | Collagen Glow Berries | Ginseng Turmeric Superjuice | Sicilian Orange Slimming Elixir; product code is 41 E - - 99 Meal Replacements (Not labeled for treatment of disease) | 54 A - - 99 Vitamin, N.E.C. | 54 A - - 99 Vitamin, N.E.C. | 54 E - - 12 Ginseng (Herbal & Botanical Teas) | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C; date published is 01/18/2024; address is No 160 Lunnei , Tuku Township , Yunlin County, Yunlin TAIWAN, verified against its source on 2026-09-16.

- **Firm:** Fengjia Biotechnology Ltd _(verified: appears in the quote below)_
- **Import alert:** 99-39
- **Import alert name:** Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- **Country:** TAIWAN _(verified: appears in the quote below)_
- **Address:** No 160 Lunnei , Tuku Township , Yunlin County, Yunlin TAIWAN _(verified: appears in the quote below)_
- **Date published:** 01/18/2024 _(verified: appears in the quote below)_
- **Product code:** 41 E - - 99 Meal Replacements (Not labeled for treatment of disease) | 54 A - - 99 Vitamin, N.E.C. | 54 A - - 99 Vitamin, N.E.C. | 54 E - - 12 Ginseng (Herbal & Botanical Teas) | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. _(verified: each item appears in the quote below)_
- **Product:** Collagen Glow Berries | Sicilian Orange Slimming Elixir | Collagen Glow Berries | Ginseng Turmeric Superjuice | Sicilian Orange Slimming Elixir _(verified: each item appears in the quote below)_
- **FDA notes:** The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(s)(2)(B) of the Act [21 U.S.C §343(s)(2)(B)] because the product label fails to bear a statement of identity as a “dietary supplement” on the principal display panel. Section 403(q)(1)(A) of the Act [21 U.S.C. §343(q)(1)(A)] because the product label fails to include a serving size with the common measure followed by the equivalent metric quantity as required by 21 CFR101.9(b)(7). Section 403(e)(2) of the Act [21 U.S.C. §343(e)(2)] because the product label fails to declare the net quantity of contents, as required by 21 CFR 101.7. Section 403(i)(2) of the Act [21 U.S.C. § 343(i)(2)] because the product label fails to declare the common or usual names of each ingredient used as required by 21 CFR 101.4 and 21 CFR 101.36. Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] because the product label fails to list the name and place of business of the manufacturer, packer, or distributor as required by 21 CFR 101.105. Section 403(r)(1)(A) of the Act [21 U.S.C. § 343(r)(1)(A)] because the product label bear nutrient content claims and it does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b), (c), (e), (g), and (n). | The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(s)(2)(B) of the Act [21 U.S.C §343(s)(2)(B)] because the product label fails to bear a statement of identity as a “dietary supplement” on the principal display panel. Section 403(q)(1)(A) of the Act [21 U.S.C. §343(q)(1)(A)] because the product label fails to include a serving size with the common measure followed by the equivalent metric quantity as required by 21 CFR101.9(b)(7). Section 403(e)(2) of the Act [21 U.S.C. §343(e)(2)] because the product label fails to declare the net quantity of contents, as required by 21 CFR 101.7. Section 403(i)(2) of the Act [21 U.S.C. § 343(i)(2)] because the product label fails to declare the common or usual names of each ingredient used as required by 21 CFR 101.4 and 21 CFR 101.36. Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] because the product label fails to list the name and place of business of the manufacturer, packer, or distributor as required by 21 CFR 101.105. Section 403(r)(1)(A) of the Act [21 U.S.C. § 343(r)(1)(A)] because the product label bear nutrient content claims and it does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b), (c), (e), (g), and (n). | The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(s)(2)(B) of the Act [21 U.S.C §343(s)(2)(B)] because the product label fails to bear a statement of identity as a “dietary supplement” on the principal display panel. Section 403(q)(1)(A) of the Act [21 U.S.C. §343(q)(1)(A)] because the product label fails to include a serving size with the common measure followed by the equivalent metric quantity as required by 21 CFR101.9(b)(7). Section 403(e)(2) of the Act [21 U.S.C. §343(e)(2)] because the product label fails to declare the net quantity of contents, as required by 21 CFR 101.7. Section 403(i)(2) of the Act [21 U.S.C. § 343(i)(2)] because the product label fails to declare the common or usual names of each ingredient used as required by 21 CFR 101.4 and 21 CFR 101.36. Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] because the product label fails to list the name and place of business of the manufacturer, packer, or distributor as required by 21 CFR 101.105. Section 403(r)(1)(A) of the Act [21 U.S.C. § 343(r)(1)(A)] because the product label bear nutrient content claims and it does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b), (c), (e), (g), and (n). | The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(s)(2)(B) of the Act [21 U.S.C §343(s)(2)(B)] because the product label fails to bear a statement of identity as a “dietary supplement” on the principal display panel. Section 403(q)(1)(A) of the Act [21 U.S.C. §343(q)(1)(A)] because the product label fails to include a serving size with the common measure followed by the equivalent metric quantity as required by 21 CFR101.9(b)(7). Section 403(e)(2) of the Act [21 U.S.C. §343(e)(2)] because the product label fails to declare the net quantity of contents, as required by 21 CFR 101.7. Section 403(i)(2) of the Act [21 U.S.C. § 343(i)(2)] because the product label fails to declare the common or usual names of each ingredient used as required by 21 CFR 101.4 and 21 CFR 101.36. Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] because the product label fails to list the name and place of business of the manufacturer, packer, or distributor as required by 21 CFR 101.105. | The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(s)(2)(B) of the Act [21 U.S.C §343(s)(2)(B)] because the product label fails to bear a statement of identity as a “dietary supplement” on the principal display panel. Section 403(q)(1)(A) of the Act [21 U.S.C. §343(q)(1)(A)] because the product label fails to include a serving size with the common measure followed by the equivalent metric quantity as required by 21 CFR101.9(b)(7). Section 403(e)(2) of the Act [21 U.S.C. §343(e)(2)] because the product label fails to declare the net quantity of contents, as required by 21 CFR 101.7. Section 403(i)(2) of the Act [21 U.S.C. § 343(i)(2)] because the product label fails to declare the common or usual names of each ingredient used as required by 21 CFR 101.4 and 21 CFR 101.36. Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] because the product label fails to list the name and place of business of the manufacturer, packer, or distributor as required by 21 CFR 101.105. Section 403(r)(1)(A) of the Act [21 U.S.C. § 343(r)(1)(A)] because the product label bear nutrient content claims and it does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b), (c), (e), (g), and (n). _(verified: each item appears in the quote below)_

## What the source says

> Fengjia Biotechnology Ltd Date Published : 01/18/2024 No 160 Lunnei , Tuku Township , Yunlin County, Yunlin TAIWAN 41 E - - 99 Meal Replacements (Not labeled for treatment of disease) Date Published: 01/18/2024 Desc: Collagen Glow Berries Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(s)(2)(B) of the Act [21 U.S.C §343(s)(2)(B)] because the product label fails to bear a statement of identity as a “dietary supplement” on the principal display panel. Section 403(q)(1)(A) of the Act [21 U.S.C. §343(q)(1)(A)] because the product label fails to include a serving size with the common measure followed by the equivalent metric quantity as required by 21 CFR101.9(b)(7). Section 403(e)(2) of the Act [21 U.S.C. §343(e)(2)] because the product label fails to declare the net quantity of contents, as required by 21 CFR 101.7. Section 403(i)(2) of the Act [21 U.S.C. § 343(i)(2)] because the product label fails to declare the common or usual names of each ingredient used as required by 21 CFR 101.4 and 21 CFR 101.36. Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] because the product label fails to list the name and place of business of the manufacturer, packer, or distributor as required by 21 CFR 101.105. Section 403(r)(1)(A) of the Act [21 U.S.C. § 343(r)(1)(A)] because the product label bear nutrient content claims and it does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b), (c), (e), (g), and (n). 54 A - - 99 Vitamin, N.E.C. Date Published: 01/18/2024 Desc: Sicilian Orange Slimming Elixir Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(s)(2)(B) of the Act [21 U.S.C §343(s)(2)(B)] because the product label fails to bear a statement of identity as a “dietary supplement” on the principal display panel. Section 403(q)(1)(A) of the Act [21 U.S.C. §343(q)(1)(A)] because the product label fails to include a serving size with the common measure followed by the equivalent metric quantity as required by 21 CFR101.9(b)(7). Section 403(e)(2) of the Act [21 U.S.C. §343(e)(2)] because the product label fails to declare the net quantity of contents, as required by 21 CFR 101.7. Section 403(i)(2) of the Act [21 U.S.C. § 343(i)(2)] because the product label fails to declare the common or usual names of each ingredient used as required by 21 CFR 101.4 and 21 CFR 101.36. Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] because the product label fails to list the name and place of business of the manufacturer, packer, or distributor as required by 21 CFR 101.105. Section 403(r)(1)(A) of the Act [21 U.S.C. § 343(r)(1)(A)] because the product label bear nutrient content claims and it does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b), (c), (e), (g), and (n). 54 A - - 99 Vitamin, N.E.C. Date Published: 01/18/2024 Desc: Collagen Glow Berries Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(s)(2)(B) of the Act [21 U.S.C §343(s)(2)(B)] because the product label fails to bear a statement of identity as a “dietary supplement” on the principal display panel. Section 403(q)(1)(A) of the Act [21 U.S.C. §343(q)(1)(A)] because the product label fails to include a serving size with the common measure followed by the equivalent metric quantity as required by 21 CFR101.9(b)(7). Section 403(e)(2) of the Act [21 U.S.C. §343(e)(2)] because the product label fails to declare the net quantity of contents, as required by 21 CFR 101.7. Section 403(i)(2) of the Act [21 U.S.C. § 343(i)(2)] because the product label fails to declare the common or usual names of each ingredient used as required by 21 CFR 101.4 and 21 CFR 101.36. Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] because the product label fails to list the name and place of business of the manufacturer, packer, or distributor as required by 21 CFR 101.105. Section 403(r)(1)(A) of the Act [21 U.S.C. § 343(r)(1)(A)] because the product label bear nutrient content claims and it does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b), (c), (e), (g), and (n). 54 E - - 12 Ginseng (Herbal & Botanical Teas) Date Published: 01/18/2024 Desc: Ginseng Turmeric Superjuice Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(s)(2)(B) of the Act [21 U.S.C §343(s)(2)(B)] because the product label fails to bear a statement of identity as a “dietary supplement” on the principal display panel. Section 403(q)(1)(A) of the Act [21 U.S.C. §343(q)(1)(A)] because the product label fails to include a serving size with the common measure followed by the equivalent metric quantity as required by 21 CFR101.9(b)(7). Section 403(e)(2) of the Act [21 U.S.C. §343(e)(2)] because the product label fails to declare the net quantity of contents, as required by 21 CFR 101.7. Section 403(i)(2) of the Act [21 U.S.C. § 343(i)(2)] because the product label fails to declare the common or usual names of each ingredient used as required by 21 CFR 101.4 and 21 CFR 101.36. Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] because the product label fails to list the name and place of business of the manufacturer, packer, or distributor as required by 21 CFR 101.105. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 01/18/2024 Desc: Sicilian Orange Slimming Elixir Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(s)(2)(B) of the Act [21 U.S.C §343(s)(2)(B)] because the product label fails to bear a statement of identity as a “dietary supplement” on the principal display panel. Section 403(q)(1)(A) of the Act [21 U.S.C. §343(q)(1)(A)] because the product label fails to include a serving size with the common measure followed by the equivalent metric quantity as required by 21 CFR101.9(b)(7). Section 403(e)(2) of the Act [21 U.S.C. §343(e)(2)] because the product label fails to declare the net quantity of contents, as required by 21 CFR 101.7. Section 403(i)(2) of the Act [21 U.S.C. § 343(i)(2)] because the product label fails to declare the common or usual names of each ingredient used as required by 21 CFR 101.4 and 21 CFR 101.36. Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] because the product label fails to list the name and place of business of the manufacturer, packer, or distributor as required by 21 CFR 101.105. Section 403(r)(1)(A) of the Act [21 U.S.C. § 343(r)(1)(A)] because the product label bear nutrient content claims and it does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b), (c), (e), (g), and (n).

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_1144.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).